Altimmune, Inc. has reached its limit for free report views

Work for Altimmune, Inc.? Upgrade Your Profile and unlock all your annual reports.

Upgrade Profile

Altimmune, Inc.

Ticker ALT

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Gaithersburg, Maryland

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Their diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide…More

Visit website

REPORT RATINGS

4.7 / 5.0 (172)

Altimmune, Inc. reports have an aggregate usefulness score of 4.7 based on 172 reviews.

Altimmune, Inc.